ReviewInternational journal of molecular sciences2024
Antibacterial Properties of Copper Oxide Nanoparticles (Review).
Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Harnessing plant growth-promoting bacteria for nanoparticle biosynthesis: a systematic review of mechanisms, agricultural applications, and biomedical potential.Bioprocess and biosystems engineering · 2026Pooled it
- Bromide-mediated pathway modulation enables energy-efficient electrosynthesis of ultralight hierarchical copper powder.RSC advances · 2026Article
- Synthesis of Modified Silver- or Copper-Loaded Silica Nanocarriers as a Tool for Curcumin Delivery.Nanomaterials (Basel, Switzerland) · 2026Article
- Advanced Antibacterial Dressings for Chronic Ulcers: Alginate-Collagen-Cotton Hydrogel Composites Functionalized with Green CuO Nanoparticles.Pharmaceutics · 2026Article
- Biochemical Modulation of FeChemistry & biodiversity · 2026Article
- Copper/Copper Oxide Nanoparticles: Biological Synthesis, Characterization and Potential Biomedical Applications: Advances and Perspectives.Pharmaceuticals (Basel, Switzerland) · 2026Review
- Electrochemical Characterization of Recovered Lead from Lead-Acid Battery Recycling Using Wet/Melt Quenching Method.Materials (Basel, Switzerland) · 2026Article
- Targeting tumor-associated bacteria in digestive system cancers: carcinogenic mechanisms and nano-regulate platform design.Journal of nanobiotechnology · 2026Review
- Antioxidant and antibacterial properties of transition metals and metal oxides for medical uses: mechanisms, design strategies, and biomedical perspectives.Nanoscale advances · 2026Review
- Green synthesis of cubic CuO nanoparticles for biomedical applications and the photodegradation of methylene blue: RSM-BBD optimization of the reaction parameters and stability studies.Nanoscale advances · 2026Article
- Review of Antimicrobial Properties of Carbon Nanomaterials.International journal of molecular sciences · 2026Review
- Metal Oxide Doping Modulates the Performances of Copper Oxide Nanoparticular Biocides.Nanomaterials (Basel, Switzerland) · 2026Article
- Article
- A Composite Based onPolymers · 2026Article
- Green mycosynthesis of a CuO/ZnO heterojunction nanocomposite using Aspergillus terreus and its antibacterial and anti-virulence activity against multidrug-resistant Escherichia coli.Scientific reports · 2026Article
- Green Synthesis of Copper Oxide Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2026Article
- Characterization of Bacillus atrophaeus Strain from the Composite Material Surface in Arctic Conditions and Its Sensitivity to CuO Nanoparticles.Current microbiology · 2026Article
- Impacts of the Herbal Antimicrobial Compounds on the Antimicrobial Potency of Green Synthesized Copper Nanoparticles.Applied biochemistry and biotechnology · 2026Article
- Copper doped hybrid nanosponges functionalized with Aplysina aerophoba extract for enhanced bioactive performance.Scientific reports · 2026Article
- Cascaded, self-decomposing messenger in MXene@Cu-MOF heterostructures for on-demand infection control and pro-angiogenic wound repair.Materials today. Bio · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The use of metal and metal oxide nanoparticles is frequently regarded as a potential solution to the issue of bacterial antibiotic resistance. Among the proposed range of nanoparticles with antibacterial properties, copper oxide nanoparticles are of particular interest. Although the antibacterial properties of copper have been known for a considerable period of time, studies on the effects of copper oxide nanomaterials with respect to biological systems have attracted considerable attention in recent years. This review presents a summary of the antibacterial properties of copper oxide nanoparticles, the mechanisms by which the antibacterial effect is realized, and the key reported methods of modifying these nanoparticles to improve their antibacterial activity. A comparative analysis of the effectiveness of these nanoparticles is presented depending on the type of microorganism, the shape of the nanoparticles, and the Gram classification of bacteria based on data from published sources. In addition, the review addresses the biological activities of copper oxide nanoparticles, including their antifungal and cytotoxic properties, as well as their "antioxidant" activity. According to the conducted analysis of the literature data, it can be concluded that copper oxide nanoparticles have a significant bacteriostatic potential with respect to a wide range of microorganisms and, in some cases, contribute to the inhibition of fungal growth. At the same time, the sensitivity of Gram-positive bacteria to the effect of copper oxide nanoparticles was often higher than that of Gram-negative bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.